Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.84%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 15.19Close
$ 9.55 - $ 70 52-Week Range
Ticker Information
Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKEROS THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KROS - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.96M | 0.84% | $ 232.84M |
| 3/31/2025 | $ 1.55M | 0.72% | $ 214.71M |
| 12/31/2024 | $ 1.93M | 54.39% | $ 3.55M |
| 9/30/2024 | $ 2.18M | 335.33% | $ 651K |
| 6/30/2024 | $ 2.35M | 866.05% | $ 271K |
| 3/31/2024 | $ 2.35M | 1003.42% | $ 234K |
| 12/31/2023 | $ 2.46M | 1631.79% | $ 151K |
| 9/30/2023 | $ 2.27M | 28425% | $ 8K |
| 6/30/2023 | $ 1.9M | 0% | $ 0 |
| 3/31/2023 | $ 2.16M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, KEROS THERAPEUTICS INC's average CapEx % has been 2433.77%.
- The median CapEx % for KEROS THERAPEUTICS INC during this period was 194.86%
- KEROS THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 28425%.
- The lowest CapEx % recorded by KEROS THERAPEUTICS INC in the same timeframe 0.72%
KEROS THERAPEUTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for KEROS THERAPEUTICS INC is calculated as follows: CapEx [ $ 294K ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ] KROS - Capital Expenditures Margin, Last 5 years
0.72%
Minimum
Mar 31, 2025
28425%
Maximum
Sep 30, 2023
2433.77%
Average
194.86%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |